Forian Inc., a provider of data analytics and information solutions, has entered into a definitive merger agreement to be acquired by a consortium of investors led by Chairman and CEO Max Wygod, along with other senior executives and existing stockholders. The all-cash transaction values the company's equity at approximately $68 million and will return Forian to private ownership.
Under the agreement, Forian stockholders will receive $2.17 per share in cash, representing a premium of approximately 22.6% to the company's unaffected closing price as of August 22, 2025. The transaction was unanimously approved by the Forian Board of Directors, acting upon the recommendation of a Special Committee of independent directors formed in response to the consortium's initial proposal.
The deal is significant for shareholders who will receive immediate cash value at a substantial premium, while allowing the company to operate without the quarterly reporting pressures and regulatory requirements of public markets. For the healthcare data analytics industry, this move reflects ongoing consolidation and the strategic value of companies with proprietary data management capabilities.
Forian will continue to be led by Max Wygod and the current leadership team following the transaction's completion, which is expected in the second quarter of 2026. The company will maintain its headquarters in Newtown, Pennsylvania and continue operating under the Forian name. Upon closing, Forian's common stock will no longer be listed on the Nasdaq Stock Market or any public exchange.
The transaction is not subject to a financing condition, with consortium members having committed to provide necessary funding through a commitment letter. The Special Committee was advised by independent financial advisor Houlihan Lokey Capital, Inc. and legal counsel including Potter Anderson & Corroon LLP. Additional information about the transaction will be available through regulatory filings with the SEC at https://www.sec.gov and on the company's investor relations website at https://forian.com/investors.
Forian provides data management capabilities and analytics solutions for life sciences, healthcare, and financial services industries, with expertise in acquiring, integrating, and commercializing large-scale healthcare data assets. The company's website at https://www.forian.com offers further details about its services and operations. The move to private ownership could enable more flexible long-term strategic planning without the short-term performance expectations of public markets.
